Spain Contraceptive Devices Market Report 2022 to 2030

Spain Contraceptive Devices Market Analysis

$ 3999

Spain's Contraceptive Devices Market is expected to witness growth from $249 Mn in 2022 to $428 Mn in 2030 with a CAGR of 7.00% for the forecasted year 2022-30. Spain's population is expanding, which is fueling a rise in the need for contraceptive methods. This is because more people are engaging in sexual activity and need reliable contraception to avoid unexpected pregnancies. The market is segmented by type and by gender. Some key players in this market include Ferrer, Laboratorios Rubió, Almirall, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10ESMD005 CATEGORY: Medical Devices GEOGRAPHY: Spain AUTHOR: Jigyasu Bhandari

Buy Now

Spain Contraceptive Devices Healthcare Market Executive Analysis

Spain's Contraceptive Devices Market is expected to witness growth from $249 Mn in 2022 to $428 Mn in 2030 with a CAGR of 7.00% for the forecasted year 2022-30. In Spain, the annual expense of public healthcare is $96.46 billion, or about $2,037.04 per individual. Prescription drug expenses make up about 13.25 billion of that total. The amount is increased annually by $34.72 billion (or $733.85 per resident) for commercial healthcare. As a result, Spain's healthcare system costs $131.17 billion annually.

A total of 220,433 infections of sexually transmitted diseases were reported in Spain in 2021, with chlamydia accounting for 58.9% of those cases, followed by gonorrhoea (16.4%) and syphilis (12.1%). Although there has been an increase in maternal mortality rates recently, with a rate of 3.1 deaths per 100,000 live births reported in 2020, the maternal mortality rate in Spain is still very low at 4.1 deaths per 100,000 live births in 2021. For individuals and couples who seek to avoid unwanted births in Spain, contraceptive methods have a number of benefits. Contraceptive methods are primarily used to avoid unplanned pregnancies, which can assist single people and couples in organising and spacing their pregnancies in accordance with their preferred schedules and way of life. Spain offers a wide range of contraceptive techniques, including non-hormonal methods like condoms, diaphragms, and intrauterine devices, as well as hormonal options like birth control tablets, patches, and injections. Individuals and couples can select the approach that best meets their requirements and tastes thanks to the many possibilities available.

Spain Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

Spain's population is expanding, which is fueling a rise in the need for contraceptive methods. This is due to the fact that more people are engaging in sexual activity and need reliable contraception to avoid unexpected pregnancies. The Spanish public is becoming more aware of the value of contraception, which is fueling a rise in the demand for contraceptive methods. This occurs as a result of people's growing awareness of the necessity of managing their reproductive health and family planning. Spain's population is changing, with more women choosing to pursue employment and higher education. This is delaying marriage and having children and increasing the demand for reliable contraception. Modern, more effective, and more user-friendly contraceptive methods are being introduced by manufacturers. This is fueling the market's demand for these products.

Market Restraints

Spain is a country with a high Catholic population, and some people and communities can have unfavourable views of contraception, which could reduce the demand for these items. Contrary to other European nations, the contraceptive device market in Spain is quite limited, which may restrict its potential for expansion and profit. With numerous well-established businesses and recent entries, the contraceptive device industry in Spain is quite competitive. Gaining market share requires manufacturers to compete on price, quality, and innovation. Spain has seen economic difficulties recently, which may have an impact on consumer expenditure and the need for contraceptive devices.

Competitive Landscape

Key Players

Ferrer (ES)
Laboratorios Rubió (ES)
Almirall (ES)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

December 2021: The Spanish pharmaceutical firm Almirall announced in December 2021 that it had reached a deal to buy the German pharmaceutical firm Hermal GmbH. Almirall's dermatology portfolio, which includes contraceptive drugs, is expanded by the acquisition.

Healthcare Policies and Regulatory Landscape

The Spanish Agency of Medicines and Medical Devices (AEMPS), which is in charge of guaranteeing the safety, effectiveness, and quality of medical devices sold in Spain, classifies contraceptive products as medical devices and regulates them. The National Health System (SNS) of Spain (the government) offers free contraceptive treatments and goods. Access to family planning advice, contraception, and sterilisation procedures are all included in this. A value-added tax (VAT) of 10% is applied to the purchase and distribution of contraceptive products in Spain, which is less than the 21% regular VAT rate. The Spanish government permits the non-prescription sale of emergency contraception, which is available at pharmacies.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.